Partnering | Partnering |
AlphaRx’s primary business strategy is to seek partnerships with pharmaceutical companies to formulate improved therapeutic products utilizing the company’s drug delivery technologies. Partnering with pharmaceutical companies is a key component of our business strategy. We have adopted a flexible partnering strategy; we may partner at a very early stage by means of research collaborations; in some cases we may develop compounds on our own and commence clinical trials before seeking development and/or commercialization partners.Licensing and Distribution Partners AlphaRx has several products available for out-licensing. The products will be jointly developed, with our partners having responsibility for clinical testing, manufacturing and marketing, while AlphaRx retains ownership of the products. Research and Development Partners AlphaRx has unrivalled expertise in formulation, development, scale-up and manufacture of proven and effective life cycle management strategies. We offer a broad range of platform technologies that can be applied to many existing drug compounds and new chemical entities for multiple therapeutic opportunities. Our drug development scientists offer additional expertise in the custom-tailoring of drug delivery to meet client’s needs, whether by parenteral, oral, transdermal, local or topical administration. Partnerships in Place The following is a list of some of the partnerships AlphaRx currently has in place. Licensing Partnership Gaia BioPharma Research Partnership U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID),
|
||
